Concord Biotech Ltd Nine Monthly Results

Gross Sales

770.2

697.97

580.58

Excise Duty

0

0

0

Net Sales

770.2

697.97

580.58

Other Operating Income

0

0

0

Other Income

35.29

28.54

27.08

Total Income

805.49

726.51

607.67

Total Expenditure

454.29

400.7

366.36

PBIDT

351.2

325.81

241.31

Interest

0.43

2.09

3.06

PBDT

350.77

323.72

238.25

Depreciation

39.76

39.87

39.85

Minority Interest Before NP

0

0

0

Tax

77.15

69.86

48.38

Deferred Tax

2.61

0.9

1.44

Reported Profit After Tax

231.26

213.09

148.59

Minority Interest After NP

0

0

0

Net Profit after Minority Interest

231.26

213.09

148.59

Extra-ordinary Items

0

0

0

Adjusted Profit After Extra-ordinary item

231.26

213.09

148.59

EPS (Unit Curr.)

22.11

20.37

14.2

Book Value (Unit Curr.)

0

0

0

Dividend (%)

0

0

0

Equity

10.46

10.46

10.46

Public Shareholding (Number)

0

0

0

Public Shareholding (%)

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

Non Encumbered - No. of Shares

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

Non Encumbered - % in Total Equity

0

0

0

PBIDTM(%)

45.59

46.67

41.56

PBDTM(%)

45.54

46.38

41.03

PATM(%)

30.02

30.52

25.59